Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of choline alfoscerate in vascular cognitive impairment patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Cognitive Impairment

Drugs mentioned

• Choline alfoscerate (choline alfoscerate)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Vascular Cognitive Impairment | Phase 4 | Status: UNKNOWN